STEMC-7007

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSTEMC-7007
Drug Alias NameSTEMC-7007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin receptor agonistsRegenerating islet-derived protein 3-alpha agonists
TargetsInsulin receptorRegenerating islet-derived protein 3-alpha
Therapy Area/IndicationsPancreatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelprogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelprogen
Active IndicationsN/A
Inactive IndicationsPancreatic Diseases

Other Information

ATC CodeN/A
Related LinksN/A